
Two executives at US-based Beta Bionics, which is partnered with both Novo Nordisk and Zealand Pharma, are switching places.
Former CEO Ed Damiano is stepping down from his executive leadership role, and Martha Goldberg Aronson has been appointed interim CEO until a replacement has been found, a company press release announces.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app